Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

BoneSupport AB Company Overview 4

BoneSupport AB Company Snapshot 4

BoneSupport AB Pipeline Products and Ongoing Clinical Trials Overview 4

BoneSupport AB – Pipeline Analysis Overview 6

Business Description 6

BoneSupport AB - Key Facts 6

BoneSupport AB - Major Products and Services 7

BoneSupport AB Pipeline Products by Development Stage 8

BoneSupport AB Ongoing Clinical Trials by Trial Status 10

BoneSupport AB Pipeline Products Overview 12

CERAMENT + Bisphosphonate 12

CERAMENT + Bisphosphonate Product Overview 12

CERAMENT + Bisphosphonates And BMP 13

CERAMENT + Bisphosphonates And BMP Product Overview 13

Cerament + BMP 14

Cerament + BMP Product Overview 14

CERAMENT + BMP And Stem Cells 15

CERAMENT + BMP And Stem Cells Product Overview 15

CERAMENT V 16

CERAMENT V Product Overview 16

CERAMENT V Clinical Trial 17

Cerament|G 18

Cerament|G Product Overview 18

Cerament|G Clinical Trial 19

Gelatin/CERAMENT 21

Gelatin/CERAMENT Product Overview 21

BoneSupport AB - Key Competitors 22

BoneSupport AB - Key Employees 23

BoneSupport AB - Key Employee Biographies 24

BoneSupport AB - Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Recent Developments 26

BoneSupport AB, Recent Developments 26

Jul 04, 2018: Hakan Johansson to start as BONESUPPORT’s CFO at the end of 2018 26

May 29, 2018: BONESUPPORT to Significantly Expand its European Sales Organization 26

May 24, 2018: BONESUPPORT Signs Strategic Agreement with Collagen Matrix to Expand Product Offering in the US 26

May 17, 2018: BONESUPPORT creates its own US Commercial Platform 27

May 04, 2018: BONESUPPORT HOLDING – Q1 Interim Report 27

Mar 21, 2018: BONESUPPORT – Positive clinical data for CERAMENT G in infection management presented at BLRS 2018 28

Mar 09, 2018: BONESUPPORT to present at Orthopaedic Research Society (ORS) 2018 Annual Meeting 28

Mar 05, 2018: BONESUPPORT to present at Canaccord Musculoskeletal Conference 29

Feb 20, 2018: BoneSupport – Q4 and 2017 Year-End Report – January – December 30

Feb 01, 2018: BONESUPPORT repays outstanding loan from Kreos 31

Appendix 32

Methodology 32

About GlobalData 35

Contact Us 35

Disclaimer 35

Summary

BoneSupport AB (BoneSupport), a subsidiary of Bonesupport Holding AB, is a orthobiologics company that develops, manufactures and markets injectable bioceramic bone graft substitutes for the treatment of fragility fractures caused by osteoporosis; bone voids and gaps caused by trauma; infection, disease or related to surgical procedures such as benign tumors, fracture malunion and others. The company’s major products include bone void filler, vancomycin-eluting synthetic bone substitute and Gentamicin antibiotic eluting bone substitute. BoneSupport also carries out various pre-clinical product candidates intended to promote bone growth. The company markets its products through a network of distributors in Europe and the US. BoneSupport is headquartered in Lund, Sweden.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company BoneSupport AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company